OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Why do some glucose‐lowering agents improve non‐alcoholic fatty liver disease whereas others do not? A narrative review in search of a unifying hypothesis
Gea Ciccarelli, Gianfranco Di Giuseppe, Francesca Cinti, et al.
Diabetes/Metabolism Research and Reviews (2023) Vol. 39, Iss. 7
Open Access | Times Cited: 5
Gea Ciccarelli, Gianfranco Di Giuseppe, Francesca Cinti, et al.
Diabetes/Metabolism Research and Reviews (2023) Vol. 39, Iss. 7
Open Access | Times Cited: 5
Showing 5 citing articles:
Exploring Nutraceutical Approaches Linking Metabolic Syndrome and Cognitive Impairment
Rebecca Sonnino, Gea Ciccarelli, Simona Moffa, et al.
iScience (2025) Vol. 28, Iss. 2, pp. 111848-111848
Open Access
Rebecca Sonnino, Gea Ciccarelli, Simona Moffa, et al.
iScience (2025) Vol. 28, Iss. 2, pp. 111848-111848
Open Access
Objective measures of cardiometabolic risk and advanced fibrosis risk progression in primary care patients with metabolic dysfunction-associated steatotic liver disease.
Andrew D. Schreiner, Jingwen Zhang, William P. Moran, et al.
Endocrine Practice (2024) Vol. 30, Iss. 11, pp. 1015-1022
Closed Access | Times Cited: 1
Andrew D. Schreiner, Jingwen Zhang, William P. Moran, et al.
Endocrine Practice (2024) Vol. 30, Iss. 11, pp. 1015-1022
Closed Access | Times Cited: 1
Prospects of using sodium-glucose co-transporter-2 (SGLT-2) inhibitors in patients with metabolic-associated fatty liver disease (MAFLD)
Iryna Kostitska, Nadia Protas, Liliia Petrovska
Diabetes Obesity Metabolic Syndrome (2023), Iss. 5, pp. 8-37
Open Access | Times Cited: 2
Iryna Kostitska, Nadia Protas, Liliia Petrovska
Diabetes Obesity Metabolic Syndrome (2023), Iss. 5, pp. 8-37
Open Access | Times Cited: 2
Bibliometric Analysis of Vitamin D and Non-Alcoholic Fatty Liver Disease
Rui Wang, Zhanjie Chang
Journal of Innovations in Medical Research (2023) Vol. 2, Iss. 6, pp. 45-54
Open Access | Times Cited: 1
Rui Wang, Zhanjie Chang
Journal of Innovations in Medical Research (2023) Vol. 2, Iss. 6, pp. 45-54
Open Access | Times Cited: 1
Daphnetin ameliorates hepatic steatosis by suppressing peroxisome proliferator-activated receptor gamma (PPARG) in ob/ob mice
Zhen Wang, Peipei Gao, Jing Gao, et al.
Biochemical Pharmacology (2024) Vol. 230, pp. 116610-116610
Closed Access
Zhen Wang, Peipei Gao, Jing Gao, et al.
Biochemical Pharmacology (2024) Vol. 230, pp. 116610-116610
Closed Access
